Neuheit Pharma Private Limited, incorporated on March 16, 2015, aimed to trade pharmaceutical products. The company's authorized share capital was Rs. 24,10,00,000, divided into 2,41,00,000 equity shares of Rs. 10 each. The issued and paid-up capital was Rs. 23,10,45,850, consisting of 2,31,04,585 equity shares of Rs. 10 each. Due to a lack of significant business operations or prospects, the Board of Directors approved a proposal for voluntary liquidation on February 5, 2021. A special resolution for voluntary liquidation was obtained on March 4, 2021, and Mr. Bathina Venka Reddy was appointed as the liquidator. Public announcements were made, and statutory authorities were informed. The company had financial assets, including cash at bank (Rs. 10,04,331), fixed

Neuheit Pharma Private Limited, incorporated on March 16, 2015, aimed to trade pharmaceutical products. The company's authorized share capital was Rs. 24,10,00,000, divided into 2,41,00,000 equity shares of Rs. 10 each. The issued and paid-up capital was Rs. 23,10,45,850, consisting of 2,31,04,585 equity shares of Rs. 10 each. Due to a lack of significant business operations or prospects, the Board of Directors approved a proposal for voluntary liquidation on February 5, 2021. A special resolution for voluntary liquidation was obtained on March 4, 2021, and Mr. Bathina Venka Reddy was appointed as the liquidator. Public announcements were made, and statutory authorities were informed. The company had financial assets, including cash at bank (Rs. 10,04,331), fixed